Defining, distinguishing and detecting the contribution of heterogeneous methylation to cancer heterogeneity

Seminars in Cell and Developmental Biology

Volumn 64, Issue , 2017, Pages 5-17

  Pisanic, Thomas R ^a   Athamanolap, Pornpat ^b   Wang, Tza Huei ^a,b,c  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cancer; DNA methylation; Epigenetics; Molecular diagnostics; Tumor heterogeneity

Indexed keywords

AGE; ALLELE; CLONE BASED BISULFITE SEQUENCING; DIRECT BISULFITE SEQUENCING; DNA METHYLATION; DNA MICROARRAY; ENVIRONMENT; EPIGENETICS; GENE LOCUS; GENE SEQUENCE; GENETIC HETEROGENEITY; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MALIGNANT NEOPLASM; MOLECULAR DIAGNOSIS; NANOPORE SEQUENCING; POLYMERASE CHAIN REACTION; REVIEW; SINGLE CELL SEQUENCING; SINGLE MLECULE REAL TIME SEQUENCING; WHOLE GENOME BISULFITE SEQUENCING; WHOLE GENOME SEQUENCING; ANIMAL; BIOLOGICAL MODEL; GENETICS; MARKOV CHAIN; NEOPLASM;

ANIMALS; DNA METHYLATION; GENETIC HETEROGENEITY; HUMANS; MODELS, GENETIC; NEOPLASMS; STOCHASTIC PROCESSES;

EID: 85021249827     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2016.08.030     Document Type: Review

References (157)

1. Holliday, R., Pugh, J., DNA modification mechanisms and gene activity during development. Science 187:4173 (1975), 226–232.
2. Riggs, A.D., X inactivation, differentiation, and DNA methylation, Cytogenet. Cell Genet. 14:1 (1975), 9–25.
3. Gama-Sosa, M.A., Slagel, V.A., Trewyn, R.W., Oxenhandler, R., Kuo, K.C., Gehrke, C.W., et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11:19 (1983), 6883–6894.
4. Feinberg, A.P., Vogelstein, B., Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:5895 (1983), 89–92.
5. Baylin, S.B., Höppener, J.W.M., de Bustros, A., Steenbergh, P.H., Lips, C.J.M., Nelkin, B.D., DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res. 46:6 (1986), 2917–2922.
6. Baylin, S.B., Herman, J.G., DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:4 (2000), 168–174.
7. Swartz, M.N., Trautner, T.A., Kornberg, A., Enzymatic synthesis of deoxyribonucleic acid: XI. further studies on nearest neighbor base sequences In deoxyribonucleic acids. J. Biol. Chem. 237:6 (1962), 1961–1967.
8. Ehrlich, M., Gama-Sosa, M.A., Huang, L.-H., Midgett, R.M., Kuo, K.C., McCune, R.A., et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells. Nucleic Acids Res. 10:8 (1982), 2709–2721.
9. Antequera, F., Bird, A., Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. U. S. A. 90:24 (1993), 11995–11999.
10. Bird, A.P., CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3 (1987), 342–347.
11. Jones, P.A., Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13:7 (2012), 484–492.
12. Schubeler, D., Function and information content of DNA methylation. Nature 517:7534 (2015), 321–326.
13. Spruijt, C.G., Vermeulen, M., DNA methylation: old dog, new tricks?. Nat Struct. Mol. Biol. 21:11 (2014), 949–954.
14. Hwang, W., Oliver, V.F., Merbs, S.L., Zhu, H., Qian, J., Prediction of promoters and enhancers using multiple DNA methylation-associated features. BMC Genomics, 16(Suppl. 7), 2015 S11–S11.
15. Martino, D., Saffery, R., Characteristics of DNA methylation and gene expression in regulatory features on the Infinium 450k Beadchip. bioRxiv, 2015.
16. Reddington, J.P., Pennings, S., Meehan, R.R., Non-canonical functions of the DNA methylome in gene regulation. Biochem. J. 451 (2013), 13–23.
17. Fatemi, M., Hermann, A., Gowher, H., Jeltsch, A., Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur. J. Biochem. 269:20 (2002), 4981–4984.
18. Kim, G.-D., Ni, J., Kelesoglu, N., Roberts, R.J., Pradhan, S., Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21:15 (2002), 4183–4195.
19. Liang, G., Chan, M.F., Tomigahara, Y., Tsai, Y.C., Gonzales, F.A., Li, E., et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 22:2 (2002), 480–491.
20. Clouaire, T., Stancheva, I., Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?. Cell. Mol. Life Sci: CMLS 65:10 (2008), 1509–1522.
21. Hill, P.W.S., Amouroux, R., Hajkova, P., DNA demethylation, tet proteins and 5-hydroxymethylcytosine in epigenetic reprogramming: an emerging complex story. Genomics 104:5 (2014), 324–333.
22. Tahiliani, M., Koh, K.P., Shen, Y.H., Pastor, W.A., Bandukwala, H., Brudno, Y., et al. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:5929 (2009), 930–935.
23. Hajkova, P., Ancelin, K., Waldmann, T., Lacoste, N., Lange, U.C., Cesari, F., et al. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452:7189 (2008), 877–881.
24. Gkountela, S., Zhang, K.X., Shafiq, T.A., Liao, W.W., Hargan-Calvopina, J., Chen, P.Y., et al. DNA demethylation dynamics in the human prenatal germline. Cell 161:6 (2015), 1425–1436.
25. Hackett, J.A., Sengupta, R., Zylicz, J.J., Murakami, K., Lee, C., Down, T.A., et al. Germline DNA demethylation dynamics and imprint erasure through 5-Hydroxymethylcytosine. Science 339:6118 (2013), 448–452.
26. Seisenberger, S., Andrews, S., Krueger, F., Arand, J., Walter, J., Santos, F., et al. The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells. Mol. Cell 48:6 (2012), 849–862.
27. Sabag, O., Zamir, A., Keshet, I., Hecht, M., Ludwig, G., Tabib, A., et al. Establishment of methylation patterns in ES cells. Nat. Struct. Mol. Biol. 21:1 (2014), 110–112.
28. Kafri, T., Ariel, M., Brandeis, M., Shemer, R., Urven, L., McCarrey, J., et al. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes. Dev. 6:5 (1992), 705–714.
29. Monk, M., Boubelik, M., Lehnert, S., Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99:3 (1987), 371–382.
30. Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Names, A., et al. Spl elements protect a CpG island from de novo methylation. Nature 371:6496 (1994), 435–438.
31. Macleod, D., Charlton, J., Mullins, J., Bird, A.P., Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes. Dev. 8:19 (1994), 2282–2292.
32. Ginno, Paul A., Lott, Paul L., Christensen, Holly C., Korf, I., Chédin, F., R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol. Cell 45:6 (2012), 814–825.
33. Timp, W., Feinberg, A.P., Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat. Rev. Cancer 13:7 (2013), 497–510.
34. Blackledge, N.P., Rose, N.R., Klose, R.J., Targeting Polycomb systems to regulate gene expression: modifications to a complex story. Nat. Rev. Mol. Cell Biol. 16:11 (2015), 643–649.
35. Brinkman, A.B., Gu, H., Bartels, S.J.J., Zhang, Y., Matarese, F., Simmer, F., et al. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res. 22:6 (2012), 1128–1138.
36. Murphy, P.J., Cipriany, B.R., Wallin, C.B., Ju, C.Y., Szeto, K., Hagarman, J.A., et al. Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells. Proc. Natl. Acad. Sci. 110:19 (2013), 7772–7777.
37. Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39:2 (2007), 232–236.
38. Landan, G., Cohen, N.M., Mukamel, Z., Bar, A., Molchadsky, A., Brosh, R., et al. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat. Genet. 44:11 (2012), 1207–1214.
39. Ayyanathan, K., Lechner, M.S., Bell, P., Maul, G.G., Schultz, D.C., Yamada, Y., et al. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes. Dev. 17:15 (2003), 1855–1869.
40. Wossidlo, M., Nakamura, T., Lepikhov, K., Marques, C.J., Zakhartchenko, V., Boiani, M., et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun., 2, 2011, 8.
41. Voigt, P., Tee, W.-W., Reinberg, D., A double take on bivalent promoters. Genes. Dev. 27:12 (2013), 1318–1338.
42. Bernstein, B.E., Mikkelsen, T.S., Xie, X.H., Kamal, M., Huebert, D.J., Cuff, J., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:2 (2006), 315–326.
43. Hagarman, J.A., Motley, M.P., Kristjansdottir, K., Soloway, P.D., Coordinate regulation of DNA methylation and H3K27me3 in mouse embryonic stem cells. PLoS One, 8(1), 2013, e53880.
44. Feldman, N., Gerson, A., Fang, J., Li, E., Zhang, Y., Shinkai, Y., et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 8:2 (2006), 188–194.
45. Kaufman, C.K., Mosimann, C., Fan, Z.P., Yang, S., Thomas, A.J., Ablain, J.,Tan J.L., Fogley R.D., Van Rooijen E., Hagedorn E.J., Ciarlo C., White R.M., Matos D.A., Puller A.-C., Santoriello C., Liao E.C., Young R.A., Zon L.I.A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science, 351(6272), 2016.
46. Law, J.A., Jacobsen, S.E., Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet. 11:3 (2010), 204–220.
47. Shipony, Z., Mukamel, Z., Cohen, N.M., Landan, G., Chomsky, E., Zeliger, S.R., et al. Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature 513:7516 (2014), 115–119.
48. Zhang, Y., Rohde, C., Tierling, S., Jurkowski, T.P., Bock, C., Santacruz, D., et al. DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet., 5(3), 2009, e1000438.
49. Bird, A., DNA methylation patterns and epigenetic memory. Genes. Dev. 16:1 (2002), 6–21.
50. Silva, A.J., Ward, K., White, R., Mosaic methylation in clonal tissue. Dev. Biol. 156:2 (1993), 391–398.
51. Ushijima, T., Watanabe, N., Okochi, E., Kaneda, A., Sugimura, T., Miyamoto, K., Fidelity of the methylation pattern and its variation in the genome. Genome Res. 13:5 (2003), 868–874.
52. Laird, C.D., Pleasant, N.D., Clark, A.D., Sneeden, J.L., Hassan, K.M.A., Manley, N.C., et al. Hairpin-bisulfite PCR: Assessing epigenetic methylation patterns on complementary strands of individual DNA molecules. Proc. Natl. Acad. Sci. U. S. A. 101:1 (2004), 204–209.
53. Jeltsch, A., Jurkowska, R.Z., New concepts in DNA methylation. Trends Biochem. Sci. 39:7 (2014), 310–318.
54. Arand, J., Spieler, D., Karius, T., Branco, M.R., Meilinger, D., Meissner, A., et al. In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases. PLoS Genet., 8(6), 2012, e1002750.
55. Riggs, A.D., Xiong, Z., Methylation and epigenetic fidelity. Proc. Natl. Acad. Sci. U. S. A. 101:1 (2004), 4–5.
56. Sneppen, K., Dodd, I.B., Nucleosome dynamics and maintenance of epigenetic states of CpG islands. Phys. Rev. E, 93(6), 2016, 8.
57. Sormani, G., Haerter, J.O., Lovkvist, C., Sneppen, K., Stabilization of epigenetic states of CpG islands by local cooperation. Mol. Biosyst. 12:7 (2016), 2142–2146.
58. Kass, S.U., Pruss, D., Wolffe, A.P., How does DNA methylation repress transcription?. Trends Genet. 13:11 (1997), 444–449.
59. Hsieh, C.L., Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14:8 (1994), 5487–5494.
60. Boyes, J., Bird, A., Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J. 11:1 (1992), 327–333.
61. Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S., Rebhan, M., et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39:4 (2007), 457–466.
62. Hansen, K.D., Timp, W., Bravo, H.C., Sabunciyan, S., Langmead, B., McDonald, O.G., et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet., 43(8), 2011 768–U77.
63. Yuan, T., Jiao, Y.M., de Jong, S., Ophoff, R.A., Beck, S., Teschendorff, A.E., An integrative multi-scale analysis of the dynamic DNA methylation landscape in aging. PLoS Genet., 11(2), 2015.
64. Zheng, S.C., Widschwendter, M., Teschendorff, A.E., Epigenetic drift, epigenetic clocks and cancer risk. Epigenomics 8:5 (2016), 705–719.
65. Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., Gao, X., et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24:2 (2000), 132–138.
66. Christensen, B.C., Houseman, E.A., Marsit, C.J., Zheng, S., Wrensch, M.R., Wiemels, J.L., et al. Aging and environmental exposures alter tissue-Specific DNA methylation dependent upon CpG island context. PLoS Genet., 5(8), 2009, e1000602.
67. Horvath, S., DNA methylation age of human tissues and cell types. Genome Biol. 14:10 (2013), 1–20.
68. Teschendorff, A.E., Menon, U., Gentry-Maharaj, A., Ramus, S.J., Weisenberger, D.J., Shen, H., et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 20:4 (2010), 440–446.
69. Rakyan, V.K., Down, T.A., Maslau, S., Andrew, T., Yang, T.-P., Beyan, H., et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 20:4 (2010), 434–439.
70. Ohm, J.E., McGarvey, K.M., Yu, X., Cheng, L., Schuebel, K.E., Cope, L., et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39:2 (2007), 237–242.
71. Loeb, L.A., Monnat, R.J., DNA polymerases and human disease. Nat. Rev. Genet. 9:8 (2008), 594–604.
72. Cao, Y., Environmental pollution and DNA methylation: carcinogenesis, clinical significance, and practical applications. Front. Med. 9:3 (2015), 261–274.
73. Cortessis, V.K., Thomas, D.C., Levine, A.J., Breton, C.V., Mack, T.M., Siegmund, K.D., et al. Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum. Genet. 131:10 (2012), 1565–1589.
74. Feil, R., Fraga, M.F., Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 13:2 (2012), 97–109.
75. Barrow, T.M., Michels, K.B., Epigenetic epidemiology of cancer. Biochem. Biophys. Res. Commun. 455:1-2 (2014), 70–83.
76. Chappell, G., Pogribny, I.P., Guyton, K.Z., Rusyn, I., Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: a systematic literature review. Mutat. Res. Rev. Mutat. Res. 768 (2016), 27–45.
77. Collotta, M., Bertazzi, P.A., Bollati, V., Epigenetics and pesticides. Toxicology 307 (2013), 35–41.
78. Ambatipudi, S., Cuenin, C., Hernandez-Vargas, H., Ghantous, A., Le Calvez-Kelm, F., Kaaks, R., et al. Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study. Epigenomics 8:5 (2016), 599–618.
79. Shukla, S.D., Velazquez, J., French, S.W., Lu, S.C., Ticku, M.K., Zakhari, S., Emerging role of epigenetics in the actions of alcohol. Alcoholism (NY) 32:9 (2008), 1525–1534.
80. Hullar, M.A.J., Fu, B.C., Diet, the gut microbiome, and epigenetics. Cancer J. 20:3 (2014), 170–175.
81. McKay, J.A., Mathers, J.C., Diet induced epigenetic changes and their implications for health. Acta Physiol. 202:2 (2011), 103–118.
82. Katiyar, S.K., Singh, T., Prasad, R., Sun, Q., Vaid, M., Epigenetic alterations in ultraviolet radiation-induced skin carcinogenesis: interaction of bioactive dietary components on epigenetic targets(). Photochem. Photobiol. 88:5 (2012), 1066–1074.
83. Fernandez, A.F., Esteller, M., Viral epigenomes in human tumorigenesis. Oncogene 29:10 (2010), 1405–1420.
84. Li, H.P., Leu, Y.W., Chang, Y.S., Epigenetic changes in virus-associated human cancers. Cell Res. 15:4 (2005), 262–271.
85. Feinberg, A.P., Koldobskiy, M.A., Gondor, A., Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat. Rev. Genet. 17:5 (2016), 284–299.
86. Plass, C., Pfister, S.M., Lindroth, A.M., Bogatyrova, O., Claus, R., Lichter, P., Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat. Rev. Genet. 14:11 (2013), 765–780.
87. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J.G., Baylin, S.B., Issa, J.-P.J., CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. 96:15 (1999), 8681–8686.
88. Hughes, L.A.E., Melotte, V., de Schrijver, J., de Maat, M., Smit, V.T.H.B.M., Bovée, J.V.M.G., et al. The CpG island methylator phenotype: what's in a name?. Cancer Res. 73:19 (2013), 5858–5868.
89. Turcan, S., Rohle, D., Goenka, A., Walsh, L.A., Fang, F., Yilmaz, E., et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483:7390 (2012), 479–483.
90. Langemeijer, S.M.C., Kuiper, R.P., Berends, M., Knops, R., Aslanyan, M.G., Massop, M., et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Genet. 41:7 (2009), 838–842.
91. Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18:6 (2010), 553–567.
92. Serra, R.W., Fang, M., Park, S.M., Hutchinson, L., Green, M.R., A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. eLife, 3, 2014, e02313.
93. Shamma, A., Suzuki, M., Hayashi, N., Kobayashi, M., Sasaki, N., Nishiuchi, T., et al. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation. Mol. Cell. Biol. 33:16 (2013), 3113–3124.
94. Teschendorff, A.E., Yang, Z., Wong, A., et al. Correlation of smoking-associated dna methylation changes in buccal cells with dna methylation changes in epithelial cancer. JAMA Oncol. 1:4 (2015), 476–485.
95. Mehari, B.Z., Cédric, V., Daniel, J., Effect of replication on epigenetic memory and consequences on gene transcription. Phys. Biol., 12(2), 2015, 026007.
96. Bell, J.T., Tsai, P.C., Yang, T.P., Pidsley, R., Nisbet, J., Glass, D., et al. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet., 8, 2012.
97. Teschendorff, A.E., Liu, X., Caren, H., Pollard, S.M., Beck, S., Widschwendter, M., et al. The dynamics of DNA methylation covariation patterns in carcinogenesis. PLoS Comput. Biol., 10(7), 2014, e1003709.
98. Teschendorff, A., Jones, A., Fiegl, H., Sargent, A., Zhuang, J., Kitchener, H., et al. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome. Med., 4, 2012.
99. De Carvalho, D.D., Sharma, S., You, J.S., Su, S.-F., Taberlay, P.C., Kelly, T.K., et al. DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell 21:5 (2012), 655–667.
100. Burgess, D.J., Epigenetics: dissecting driving DNA methylations. Nat. Rev. Cancer 12:7 (2012), 448–449.
101. West, J., Widschwendter, M., Teschendorff, A.E., Distinctive topology of age-associated epigenetic drift in the human interactome. Proc. Natl. Acad. Sci. U. S. A. 110:35 (2013), 14138–14143.
102. Keshet, I., Schlesinger, Y., Farkash, S., Rand, E., Hecht, M., Segal, E., Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet., 38, 2006.
103. Aranda, S., Mas, G., Di Croce, L., Regulation of gene transcription by Polycomb proteins. Sci. Adv., 1(11), 2015, e1500737.
104. Saksouk, N., Barth, Teresa K., Ziegler-Birling, C., Olova, N., Nowak, A., Rey, E., et al. Redundant mechanisms to form silent chromatin at pericentromeric regions rely on BEND3 and DNA methylation. Mol. Cell 56:4 (2014), 580–594.
105. Aryee, M.J., Liu, W., Engelmann, J.C., Nuhn, P., Gurel, M., Haffner, M.C., et al. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci. Transl. Med., 5(169), 2013 169ra10–169ra10.
106. Mazor, T., Pankov, A., Song, Jun S., Costello, Joseph F., Intratumoral heterogeneity of the epigenome. Cancer Cell 29:4 (2016), 440–451.
107. Easwaran, H., Tsai, H.-C., Baylin, S.B., Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol. Cell 54:5 (2014), 716–727.
108. Tam, W.L., Weinberg, R.A., The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat. Med. 19:11 (2013), 1438–1449.
109. Moarii, M., Boeva, V., Vert, J.-P., Reyal, F., Changes in correlation between promoter methylation and gene expression in cancer. BMC Genomics 16:1 (2015), 1–14.
110. Belinsky, S.A., Nikula, K.J., Palmisano, W.A., Michels, R., Saccomanno, G., Gabrielson, E., et al. Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. 95:20 (1998), 11891–11896.
111. Suzuki, H., Watkins, D.N., Jair, K.-W., Schuebel, K.E., Markowitz, S.D., Dong Chen, W., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36:4 (2004), 417–422.
112. Chim, C.-S., Fung, T.-K., Cheung, W.-C., Liang, R., Kwong, Y.-L., SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. Blood 103:12 (2004), 4630–4635.
113. van Engeland, M., Roemen, G., Brink, M., Paachen, M.M.M., Weijenberg, M.P., de Bruine, A.P., et al. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 21:23 (2002), 3792–3795.
114. Toyota, M., Sasaki, Y., Satoh, A., Ogi, K., Kikuchi, T., Suzuki, H., et al. Epigenetic inactivation of CHFR in human tumors. Proc. Natl. Acad. Sci. U. S. A. 100:13 (2003), 7818–7823.
115. Bhutani, N., Brady, J.J., Damian, M., Sacco, A., Corbel, S.Y., Blau, H.M., Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463:7284 (2010), 1042–1047.
116. Shi, J.L., Shi, W., Ni, L.C., Xu, X.D., Su, X., Xia, L., et al. OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas. Oncol. Rep. 30:1 (2013), 201–206.
117. Doege, C.A., Inoue, K., Yamashita, T., Rhee, D.B., Travis, S., Fujita, R., et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 488:7413 (2012), 652–655.
118. You, H., Ding, W., Rountree, C.B., Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β. Hepatology 51:5 (2010), 1635–1644.
119. McGranahan, N., Swanton, C., Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27:1 (2015), 15–26.
120. Moelans, C.B., de Groot, J.S., Pan, X., van der Wall, E., van Diest, P.J., Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA. Mod. Pathol. 27:6 (2014), 869–874.
121. Siegmund, K.D., Marjoram, P., Woo, Y.-J., Tavaré, S., Shibata, D., Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers. Proc. Natl. Acad. Sci. 106:12 (2009), 4828–4833.
122. Nishino, K., Toyoda, M., Yamazaki-Inoue, M., Fukawatase, Y., Chikazawa, E., Sakaguchi, H., et al. DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet., 7(5), 2011, e1002085.
123. Carmona, F.J., Davalos, V., Vidal, E., Gomez, A., Heyn, H., Hashimoto, Y., et al. A comprehensive DNA methylation profile of epithelial-to-Mesenchymal transition. Cancer Res. 74:19 (2014), 5608–5619.
124. Claus, R., Gu, L., Assenov, Y., Hüllein, J., Zucknick, M., Brocks, D., et al. Heterogeneity and evolution of DNA methylation In chronic Lymphocytic Leukemia. Blood, 122(21), 2013 1626–1626.
125. Oakes, C.C., Claus, R., Gu, L., Assenov, Y., Hüllein, J., Zucknick, M., et al. Evolution of DNA methylation is linked to genetic aberrations in chronic Lymphocytic Leukemia. Cancer Discovery 4:3 (2014), 348–361.
126. Frommer, M., Mcdonald, L.E., Millar, D.S., Collis, C.M., Watt, F., Grigg, G.W., et al. A genomic sequencing protocol that yields a positive display of 5-Methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. U. S. A. 89:5 (1992), 1827–1831.
127. Lewin, J., Schmitt, A.O., Adorjan, P., Hildmann, T., Piepenbrock, C., Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20:17 (2004), 3005–3012.
128. Colella, S., Shen, L., Baggerly, K.A., Issa, J.P., Krahe, R., Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35:1 (2003), 146–150.
129. Taylor, K.H., Kramer, R.S., Davis, J.W., Guo, J., Duff, D.J., Xu, D., et al. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res. 67:18 (2007), 8511–8518.
130. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D., Baylin, S.B., Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93:18 (1996), 9821–9826.
131. Lo, Y.M., Wong, I.H., Zhang, J., Tein, M.S., Ng, M.H., Hjelm, N.M., Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res. 59:16 (1999), 3899–3903.
132. Eads, C.A., Danenberg, K.D., Kawakami, K., Saltz, L.B., Blake, C., Shibata, D., et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res., 28(8), 2000, E32.
133. Wojdacz, T.K., Dobrovic, A., Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res., 35(6), 2007, e41.
134. Lin, T.C., Jiang, S.S., Chou, W.C., Hou, H.A., Lin, Y.M., Chang, C.L., et al. Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute Myeloid Leukemia by using high-resolution melting profile. J. Mol. Diagn. 13:5 (2011), 514–519.
135. Candiloro, I.L.M., Mikeska, T., Hokland, P., Dobrovic, A., Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2 B (p15) gene. Epigenet. Chromatin., 1, 2008.
136. Pisanic, T.R., Athamanolap, P., Poh, W., Chen, C., Hulbert, A., Brock, M.V., et al. DREAMing: a simple and ultrasensitive method for assessing intratumor epigenetic heterogeneity directly from liquid biopsies. Nucleic Acids Res., 43(22), 2015.
137. Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K.W., Vogelstein, B., Detection and quantification of rare mutations with massively parallel sequencing. Proc. Natl. Acad. Sci. 108:23 (2011), 9530–9535.
138. Kennedy, S.R., Schmitt, M.W., Fox, E.J., Kohrn, B.F., Salk, J.J., Ahn, E.H., et al. Detecting ultralow-frequency mutations by duplex sequencing. Nat. Protocols 9:11 (2014), 2586–2606.
139. Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini, J., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:7271 (2009), 315–322.
140. Berman, B.P., Weisenberger, D.J., Aman, J.F., Hinoue, T., Ramjan, Z., Liu, Y.P., et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat. Genet. 44:1 (2012), 40–U62.
141. Heyn, H., Li, N., Ferreira, H.J., Moran, S., Pisano, D.G., Gomez, A., et al. Distinct DNA methylomes of newborns and centenarians. Proc. Natl. Acad. Sci. U. S. A. 109:26 (2012), 10522–10527.
142. Ziller, M.J., Gu, H.C., Muller, F., Donaghey, J., Tsai, L.T.Y., Kohlbacher, O., et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 500:7463 (2013), 477–481.
143. Meissner, A., Gnirke, A., Bell, G.W., Ramsahoye, B., Lander, E.S., Jaenisch, R., Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 33:18 (2005), 5868–5877.
144. Guo, H.S., Zhu, P., Wu, X.L., Li, X.L., Wen, L., Tang, F.C., Single-cell methylome landscapes of mouse embryonic stem cells and early embryos analyzed using reduced representation bisulfite sequencing. Genome Res. 23:12 (2013), 2126–2135.
145. Smallwood, S.A., Lee, H.J., Angermueller, C., Krueger, F., Saadeh, H., Peat, J., et al. Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat. Methods 11:8 (2014), 817–820.
146. Farlik, M., Sheffield, N.C., Nuzzo, A., Datlinger, P., Schonegger, A., Klughammer, J., et al. Single-cell DNA methylome sequencing and bioinformatic inference of epigenomic cell-State dynamics. Cell Rep. 10:8 (2015), 1386–1397.
147. Weisenberger, D.J., Characterizing DNA methylation alterations from the cancer genome atlas. J. Clin. Invest. 124:1 (2014), 17–23.
148. Chen, Y.A., Lemire, M., Choufani, S., Butcher, D.T., Grafodatskaya, D., Zanke, B.W., et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8:2 (2013), 203–209.
149. Moran, S., Arribas, C., Esteller, M., Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics 8:3 (2016), 389–399.
150. Eid, J., Fehr, A., Gray, J., Luong, K., Lyle, J., Otto, G., et al. Real-time DNA sequencing from single polymerase molecules. Science 323:5910 (2009), 133–138.
151. Flusberg, B.A., Webster, D.R., Lee, J.H., Travers, K.J., Olivares, E.C., Clark, T.A., et al. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat. Methods, 7(6), 2010 461–U72.
152. Ross, M.G., Russ, C., Costello, M., Hollinger, A., Lennon, N.J., Hegarty, R., et al. Characterizing and measuring bias in sequence data. Genome Biol., 14(5), 2013.
153. Laszlo, A.H., Derrington, I.M., Brinkerhoff, H., Langford, K.W., Nova, I.C., Samson, J.M., et al. Detection and mapping of 5-methylcytosine and 5-hydroxymethylcytosine with nanopore MspA. Proc. Natl. Acad. Sci. U. S. A. 110:47 (2013), 18904–18909.
154. Shim, J., Humphreys, G.I., Venkatesan, B.M., Munz, J.M., Zou, X.Q., Sathe, C., et al. Detection and quantification of methylation in DNA using solid-State nanopores. Sci. Rep. Uk, 3, 2013.
155. Schreiber, J., Wescoe, Z.L., Abu-Shumays, R., Vivian, J.T., Baatar, B., Karplus, K., et al. Error rates for nanopore discrimination among cytosine, methylcytosine, and hydroxymethylcytosine along individual DNA strands. Proc. Natl. Acad. Sci. 110:47 (2013), 18910–18915.
156. Laszlo, A.H., Derrington, I.M., Brinkerhoff, H., Langford, K.W., Nova, I.C., Samson, J.M., et al. Detection and mapping of 5-methylcytosine and 5-hydroxymethylcytosine with nanopore MspA. Proc. Natl. Acad. Sci. 110:47 (2013), 18904–18909.
157. Simpson, J.T., Workman, R., Zuzarte, P.C., David, M., Dursi, L.J., Timp, W., Detecting DNA methylation using the oxford nanopore technologies MinION sequencer. bioRxiv, 2016.